“…Our data thus suggest that functional autophagy remain intact when beclin 1 was deleted while DNA DSB repair is dependent on Beclin 1. These results are in contrast to the results of a recent study that reported that deletion of beclin 1 using TALEN disrupted autophagic flux by disrupting the formation of autophagosomes but not by disrupting LC3b lipidation in human Hela cells33. However, the present data appear to be consistent with our recent finding that somatic cells, but not stem cells, can acquire an alternative form of autophagy when their canonical autophagy pathway is disrupted3435.…”
Beclin 1 is a well-established core mammalian autophagy protein that is embryonically indispensable and has been presumed to suppress oncogenesis via an autophagy-mediated mechanism. Here, we show that Beclin 1 is a prenatal primary cytoplasmic protein but rapidly relocated into the nucleus during postnatal development in mice. Surprisingly, deletion of beclin1 in in vitro human cells did not block an autophagy response, but attenuated the expression of several DNA double-strand break (DSB) repair proteins and formation of repair complexes, and reduced an ability to repair DNA in the cells exposed to ionizing radiation (IR). Overexpressing Beclin 1 improved the repair of IR-induced DSB, but did not restore an autophagy response in cells lacking autophagy gene Atg7, suggesting that Beclin 1 may regulate DSB repair independent of autophagy in the cells exposed to IR. Indeed, we found that Beclin 1 could directly interact with DNA topoisomerase IIβ and was recruited to the DSB sites by the interaction. These findings reveal a novel function of Beclin 1 in regulation of DNA damage repair independent of its role in autophagy particularly when the cells are under radiation insult.
“…Our data thus suggest that functional autophagy remain intact when beclin 1 was deleted while DNA DSB repair is dependent on Beclin 1. These results are in contrast to the results of a recent study that reported that deletion of beclin 1 using TALEN disrupted autophagic flux by disrupting the formation of autophagosomes but not by disrupting LC3b lipidation in human Hela cells33. However, the present data appear to be consistent with our recent finding that somatic cells, but not stem cells, can acquire an alternative form of autophagy when their canonical autophagy pathway is disrupted3435.…”
Beclin 1 is a well-established core mammalian autophagy protein that is embryonically indispensable and has been presumed to suppress oncogenesis via an autophagy-mediated mechanism. Here, we show that Beclin 1 is a prenatal primary cytoplasmic protein but rapidly relocated into the nucleus during postnatal development in mice. Surprisingly, deletion of beclin1 in in vitro human cells did not block an autophagy response, but attenuated the expression of several DNA double-strand break (DSB) repair proteins and formation of repair complexes, and reduced an ability to repair DNA in the cells exposed to ionizing radiation (IR). Overexpressing Beclin 1 improved the repair of IR-induced DSB, but did not restore an autophagy response in cells lacking autophagy gene Atg7, suggesting that Beclin 1 may regulate DSB repair independent of autophagy in the cells exposed to IR. Indeed, we found that Beclin 1 could directly interact with DNA topoisomerase IIβ and was recruited to the DSB sites by the interaction. These findings reveal a novel function of Beclin 1 in regulation of DNA damage repair independent of its role in autophagy particularly when the cells are under radiation insult.
“…We confirmed the attenuation of starvation-induced autophagic activity by showing the reduction in LC3 puncta formation and LC3-II levels (S3D, S3E and S3F Fig) in Beclin 1 KO cells. These results were not inconsistent with that of a previous study [30]. …”
Anti-apoptotic Bcl-2 and Bcl-xL are proposed to regulate starvation-induced autophagy by directly interacting with Beclin 1. Beclin 1 is also thought to be involved in multiple vesicle trafficking pathways such as endocytosis by binding to Atg14L and UVRAG. However, how the interaction of Bcl-2 family proteins and Beclin 1 regulates anti-bacterial autophagy (xenophagy) is still unclear. In this study, we analyzed these interactions using Group A Streptococcus (GAS; Streptococcus pyogenes) infection as a model. GAS is internalized into epithelial cells through endocytosis, while the intracellular fate of GAS is degradation by autophagy. Here, we found that Bcl-xL but not Bcl-2 regulates GAS-induced autophagy. Autophagosome-lysosome fusion and the internalization process during GAS infection were promoted in Bcl-xL knockout cells. In addition, knockout of Beclin 1 phenocopied the internalization defect of GAS. Furthermore, UVRAG interacts not only with Beclin 1 but also with Bcl-xL, and overexpression of UVRAG partially rescued the internalization defect of Beclin 1 knockout cells during GAS infection. Thus, our results indicate that Bcl-xL inhibits GAS-induced autophagy directly by suppressing autophagosome-lysosome fusion and indirectly by suppressing GAS internalization via interaction with Beclin 1-UVRAG.
“…LC3 appears as LC3-I and LC3-II in the cytoplasm, but LC3-I is converted to LC3-II when autophagy occurs. LC3-II is the significant protein of autophagosome which is considered as the molecular marker of autophagosome, so the ratio of LC3-II/ LC3-I was employed to reflect the degree of cell autophagy [15]. Our findings showed that the ratio of LC3-II/LC3-I in MG63 cell was remarkably lower than that in osteoblast, revealing the lower autophagy activity of MG63 cells compared with normal cells.…”
Up-regulating the autophagy significantly reduced the sensitivity of MG63 cell to chemotherapy with DDP. DDP induced autophagy of MG63 cell and blocked the cell cycle at G1 phase.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.